US2014058129A1PendingUtilityA1
Phenylacetic Acid Derivatives
Est. expiryJun 26, 2026(expired)· nominal 20-yr term from priority
A61P 9/00A61P 9/10A61P 37/08A61P 43/00A61P 37/06A61P 35/00A61P 25/06A61P 25/00A61P 25/16A61P 25/04A61P 25/28A61P 29/00A61P 27/02A61P 15/00A61P 11/06A61P 19/10A61P 19/06A61P 19/00A61P 17/02A61P 17/06A61P 19/02C07C 227/22C07C 227/02C07C 229/42A61K 31/196C07C 229/58C07C 211/56A61P 5/24
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compounds of formula (I) pharmaceutically acceptable salts thereof; and pharmaceutically acceptable esters thereof; which are useful for the treatment of COX-2 dependent disorders.
Claims
exact text as granted — not AI-modified1 - 12 . (canceled)
13 . A method for the preparation of a compound of formula (I)
wherein
R is methyl or ethyl;
R 3 is halo or C 1 -C 6 alkyl;
R 4 is C 1 -C 6 alkyl;
R 5 is halo;
the above mentioned C 1 -C 6 alkyl at R3 and R4 being optionally substituted by one or more halo groups;
which method comprises the step of:
(a) coupling a compound of formula (II) or (III)
wherein
Z is bromo or iodo;
R has meaning as defined above;
R a is hydrogen, an alkali metal cation or lower alkyl, preferably isopropyl; and
R 6 and R 7 are lower alkyl; or R 6 and R 7 , together with the nitrogen atom, represent morpholino, piperidino or pyrrolidino;
with a compound of formula (IV)
wherein R 3 -R 5 have meaning as defined above in the presence of copper and cuprous iodide to obtain a compound of formula (V) or (VI)
and hydrolyzing the resulting compound of formula (V) or (VI) to a compound of formula (I); or
(b) condensing a compound of formula (VII)
wherein R 3 -R 7 have meaning as defined herein, with a reactive functional derivative of an acid, e.g., acetic acid, such as acetyl chloride, in a Friedel-Crafts acylation to reaction to obtain, e.g., a compound of the formula (VIII)
wherein R 3 -R 7 have meaning as defined herein, which is in turn hydrogenolyzed and then hydrolyzed to obtain a compound of formula (I), wherein R represents, e.g., ethyl; or
(c) hydrolyzing a lactam of formula (IX)
wherein R and R 3 -R 5 have meaning as defined herein, with a strong base; and in above processes, if desired, temporarily protecting any interfering reactive groups and then isolating the resulting compound of the invention; and, if desired, converting any resulting compound into another compound of the invention; and/or if desired converting a free carboxylic acid of the invention into a pharmaceutically acceptable ester derivative thereof; and/or if desired, converting a resulting free acid into a salt or a resulting salt into the free acid or into another salt.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.